Americana Partners LLC boosted its position in Danaher Co. (NYSE:DHR – Free Report) by 1,142.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,527 shares of the conglomerate’s stock after buying an additional 23,472 shares during the quarter. Americana Partners LLC’s holdings in Danaher were worth $5,860,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also bought and sold shares of the company. Heck Capital Advisors LLC purchased a new stake in Danaher in the fourth quarter worth $27,000. Decker Retirement Planning Inc. bought a new position in shares of Danaher in the fourth quarter worth $31,000. Golden State Wealth Management LLC bought a new position in shares of Danaher in the fourth quarter worth $31,000. Strategic Financial Concepts LLC bought a new position in shares of Danaher in the fourth quarter worth $31,000. Finally, Pineridge Advisors LLC boosted its holdings in shares of Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after acquiring an additional 57 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.
Insider Transactions at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 11.10% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on DHR
Danaher Stock Up 1.5 %
DHR opened at $206.66 on Monday. The company has a market cap of $149.26 billion, a P/E ratio of 39.14, a P/E/G ratio of 2.68 and a beta of 0.83. The business’s 50-day moving average price is $229.53 and its 200-day moving average price is $249.33. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the prior year, the company earned $2.09 EPS. On average, equities analysts expect that Danaher Co. will post 7.67 EPS for the current year.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.52%. Danaher’s dividend payout ratio is currently 20.45%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- Quiet Period Expirations Explained
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- Do ETFs Pay Dividends? What You Need to Know
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Expert Stock Trading Psychology Tips
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.